| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/07/1999 | WO1998028333A3 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889131A2 Staphylococcus aureus gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889130A2 GidB polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889128A2 midA1 polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889127A1 Serine/threonine protein kinase (H-SGK2) |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889125A1 Monoclonal antibody 4G8b4b12 to human FLT3/FLK2 |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889122A2 Inhibition of DNA Methyltransferase |
| 01/07/1999 | EP0889054A2 Antibody 67D2 against CD164 |
| 01/07/1999 | EP0889052A2 Immunoreactive peptides from Epstein-Barr virus |
| 01/07/1999 | EP0888551A1 Method for predicting the outcome of hepatitis b infection |
| 01/07/1999 | EP0888543A1 Azatide peptidomimetics |
| 01/07/1999 | EP0888461A1 Tissue remodeling proteins |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888385A2 Uses of gdnf and gdnf receptor |
| 01/07/1999 | EP0888381A1 Targeted therapeutic or diagnostic agents and methods of making and using same |
| 01/07/1999 | EP0888377A1 MURINE $g(a)(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 01/07/1999 | EP0888375A1 A novel disintegrin metalloprotease and methods of use |
| 01/07/1999 | EP0888370A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/07/1999 | EP0888126A1 Anti-idiotypic antibody vaccines |
| 01/07/1999 | EP0888125A1 Glycosylated humanized b-cell specific antibodies |
| 01/07/1999 | EP0888122A1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 01/07/1999 | EP0888053A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 01/07/1999 | EP0651818B1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 01/07/1999 | EP0587788B1 Methods and compositions of genetic stress response systems |
| 01/07/1999 | DE19728834A1 Eisenreduktase Ferric reductase |
| 01/07/1999 | CA2665707A1 Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum |
| 01/07/1999 | CA2427749A1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor |
| 01/07/1999 | CA2295925A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | CA2295326A1 Cardiotrophin-like cytokine |
| 01/07/1999 | CA2295319A1 New human cathepsin |
| 01/07/1999 | CA2295315A1 Targeted gene transfer using g protein coupled receptors |
| 01/07/1999 | CA2295311A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | CA2295303A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | CA2295208A1 Calcium-binding phosphoprotein |
| 01/07/1999 | CA2294704A1 Protein that binds trail |
| 01/07/1999 | CA2294604A1 Transgenic animals expressing human fc receptors |
| 01/07/1999 | CA2294473A1 Novel family of pheromone receptors |
| 01/07/1999 | CA2294131A1 Site-directed chemotherapy of metastases |
| 01/07/1999 | CA2292379A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 01/06/1999 | CN1204368A Cellulases, genes encoding them and uses thereof |
| 01/06/1999 | CN1204344A Transferrin receptor protein of Moraxella |
| 01/06/1999 | CN1203922A Humanized anti-human fas antibody |
| 01/05/1999 | US5856457 To obtain dna encoding pf4a receptors, and to express them in host cells. |
| 01/05/1999 | US5856456 Connecting polypeptides |
| 01/05/1999 | US5856452 Oil bodies and associated proteins as affinity matrices |
| 01/05/1999 | US5856448 Materials involved in the control of the cardiovascular system, and in particular to activities mediated by thrombin and its cellular receptor. |
| 01/05/1999 | US5856447 Vaccine against lyme disease |
| 01/05/1999 | US5856441 Serrate fragments and derivatives |
| 01/05/1999 | US5856306 Oligopeptides modified with boron fragment |
| 01/05/1999 | US5856297 Human C3b/C4b receptor (CR1) |
| 01/05/1999 | US5856296 DNA encoding interleukin-4 receptors |
| 01/05/1999 | US5856201 Methods of detection using a cellulose binding domain fusion product |
| 01/05/1999 | US5856184 Isolated domains of type IV collagen to modify cell and tissue interactions |
| 01/05/1999 | US5856182 Monoclonal antibodies specific for the PSA-ACT complex |
| 01/05/1999 | US5856162 Receptor-type phosphotyrosine phosphatase-κ |
| 01/05/1999 | US5856140 Human interleukin-2 response blocker |
| 01/05/1999 | US5856136 Human stem cell antigens |
| 01/05/1999 | US5856135 Reshaped human antibody to human interleukin-6 |
| 01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
| 01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/05/1999 | US5856129 Hydridized detector |
| 01/05/1999 | US5856106 Immune response to a glycoprotein |
| 01/05/1999 | US5856098 Detection of this receptor variant in cells of obese individuals, and methods for treating obesity by targeting variant. |
| 01/05/1999 | US5856087 Method for detecting immune response to hepatitis B |
| 01/05/1999 | US5856084 Recombinant dna molecules which code for polypeptides having specificity towards a hepatitis b viral antigen. |
| 01/05/1999 | US5855889 Polypeptide antibody |
| 01/05/1999 | US5855888 Monoclonal antibody which recognizes specifically extracellular region of human vla-2, .alpha. chain. the above drug for the treatment can suppress swelling with low toxicity |
| 01/05/1999 | US5855886 Immunoassay method involving fewer, preferably only one, reaction steps than conventional immunoassay in a therapeutic application, two prodrugs may be released which only become active for treatment when both are present. |
| 01/05/1999 | US5855884 Administering an antibody, a corticotropin releasing hormone inhibitor to treat stress related migraine or headache |
| 01/05/1999 | US5855866 Constructs designed to have a cytotoxic or otherwise anticellular effect against tumor vasculature |
| 01/05/1999 | CA2078373C Peptides for the production of preparations for the diagnosis and therapy of systemic lupus |
| 01/05/1999 | CA2045640C Receptor membranes and ionophore gating |
| 01/05/1999 | CA1340301C Vaccines against animal parasitic nematodes |
| 01/03/1999 | CA2236462A1 Murc |
| 01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
| 01/01/1999 | CA2236459A1 Novel compounds |
| 01/01/1999 | CA2236452A1 Gida1 |
| 01/01/1999 | CA2236441A1 Gida2 |
| 01/01/1999 | CA2236435A1 Gida2 |
| 01/01/1999 | CA2236425A1 Gida1 |
| 01/01/1999 | CA2235785A1 Serine/threonine protein kinase (h-sgk2) |
| 12/30/1998 | WO1998059248A1 Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins |
| 12/30/1998 | WO1998059246A1 C-peptide specific assay procedure |
| 12/30/1998 | WO1998059063A2 Bovine adenovirus type 3 genome |
| 12/30/1998 | WO1998059058A2 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
| 12/30/1998 | WO1998059053A1 Immonogenic fragments of toxin a of clostridium difficile |
| 12/30/1998 | WO1998059049A1 Reagents and methods useful for detecting diseases of the breast |
| 12/30/1998 | WO1998059047A1 Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method |
| 12/30/1998 | WO1998059040A2 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 12/30/1998 | WO1998059039A1 Receptor kinase, bin1 |
| 12/30/1998 | WO1998058966A1 A composition for specific immunoprotection and method for obtaining said composition |
| 12/30/1998 | WO1998058965A2 B7-binding molecules for treating immune diseases |
| 12/30/1998 | WO1998058964A1 Methods and compositions for galactosylated glycoproteins |
| 12/30/1998 | WO1998058963A1 Method for producing polyclonal and monoclonal antibodies |
| 12/30/1998 | WO1998058953A2 Surface exposed proteins from chlamydia pneumoniae |
| 12/30/1998 | WO1998058678A1 Anti-cd40l immunotoxins for the treatment of diseases |